Achyut Healthcare Intrinsic Value
Achyut Healthcare intrinsic value. Achyut Healthcare (ACHYUT) median intrinsic value is ₹10.00 from 3 valuation models (range ₹4–₹14), vs current price ₹5.66 — +76.7% upside (Trading Below Calculated Value), margin of safety 43.4%. Compare with ACHYUT fair price to assess whether the stock is under or overvalued.
ACHYUT Valuation Methods Summary — DCF, Graham Number & P/E
Achyut Healthcare intrinsic value across 3 models vs current price ₹5.66 — upside/downside and value range per method. For current market price and key ratios, visit ACHYUT screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹14.15 | ₹12.74 - ₹15.57 | +150.0% | Book Value/Share: ₹14.58, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹10.00 | ₹9.00 - ₹11.00 | +76.7% | Revenue/Share: ₹5.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹4.17 | ₹3.75 - ₹4.59 | -26.3% | EBITDA: ₹1.00Cr, EV/EBITDA: 10x |
ACHYUT Intrinsic Value vs Market Price — All Valuation Models
Achyut Healthcare fair value range ₹4–₹14 vs current market price ₹5.66 across 3 valuation models. Read ACHYUT dividend yield for the complete payout history and dividend yield track record.
ACHYUT Intrinsic Value Analysis — Undervalued or Overvalued?
Achyut Healthcare median intrinsic value ₹10.00, current price ₹5.66 — Trading Below Calculated Value by 76.7%, margin of safety 43.4%.
What is the intrinsic value of ACHYUT?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Achyut Healthcare (ACHYUT) is ₹10.00 (median value). With the current market price of ₹5.66, this represents a +76.7% variance from our estimated fair value.
The valuation range spans from ₹4.17 to ₹14.15, indicating ₹4.17 - ₹14.15.
Is ACHYUT undervalued or overvalued?
Based on our multi-method analysis, Achyut Healthcare (ACHYUT) appears to be trading below calculated value by approximately 76.7%.
ACHYUT Financial Health — Key Ratios vs Industry Benchmarks
Achyut Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 8.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.32x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
ACHYUT Cash Flow Quality — Operating & Free Cash Flow
Achyut Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹-4 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-7 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |